Risk of Post-COVID Condition Under Hybrid Immunity - Results from the German National Cohort (NAKO)
Rafael Mikolajczyk(Luther University), André Karch(University of Münster), Henry Völzke(Universitätsmedizin Greifswald), Leo Panreck, Peter Ahnert, Cornelia Gottschick(Martin Luther University Halle-Wittenberg), Claudia Meinke‐Franze(Universitätsmedizin Greifswald), Wolfgang Lieb(Christian-Albrechts-Universität zu Kiel), Sabine Gabrysch(Heidelberg University), Sylvia Gastell(German Institute of Human Nutrition), Barbara Bohn(Universität Ulm), Laura Pfrommer(Luther University), Julia Fricke(Charité - Universitätsmedizin Berlin), Ilais Moreno Velásquez(Max Delbrück Center), Rudolf Kaaks(German Cancer Research Center), Michael F. Leitzmann(University of Regensburg), Tamara Schikowski(Bielefeld University), Börge Schmidt(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Volker Harth(Universität Hamburg), Hajo Zeeb(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Andrea Weber(University of Regensburg), Bernd Holleczek(Krebsregister Saarland), Stefanie Castell(Helmholtz Centre for Infection Research), Tobias Pischon(Max Delbrück Center), Sophie Diexer(Medical University of Vienna), Jana-Kristin Heise(Helmholtz Centre for Infection Research), Nadia Obi(Universität Hamburg), Oliver Purschke(German Centre for Integrative Biodiversity Research), Thomas Keil(University of Würzburg), Marie Standl(Center for Environmental Health), Hermann Brenner(Universidad de Granada), Andreas Stang(Boston University), Lilian Krist(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Annette Peters(Zimmer Biomet (Netherlands)), Christoph Buck(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Karin Halina Greiser(Heidelberg University), K. B. Michels(Cancer Prevention Institute of California), Bianca Klee(Luther University)
Cited by 2
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k